Marylyn D. Ritchie

Last updated

Marylyn D. Ritchie is a Professor of Genetics, the Director of the Institute for Biomedical Informatics, the Director of the Division of Informatics, and the co-Director of the Penn Medicine BioBank at the University of Pennsylvania's Perelman School of Medicine. She is also the Vice President for Research Informatics at the University of Pennsylvania Health System. [1]

Contents

Career

Marylyn D. Ritchie has published many papers in peer-reviewed journals such as the American Journal of Human Genetics , the Journal of Biological Chemistry , Human Molecular Genetics , Bioinformatics , and PLOS Genetics . Previously, she was an associate professor at Vanderbilt University in the Department of Molecular Physiology and Biophysics and the Department of Biomedical Informatics. She has also served as a consultant for Boehringer-Ingelheim, one of the world's leading pharmaceutical companies. [2]

In 2018 she was appointed to the Center for Translational Genomics and the Institute for Biomedical Informatics at the University of Pennsylvania. [3]

She is the editor-in-chief of the BioData Mining journal since 2016.

Research interests

Her main research interests are Bioinformatics, Computational Genomics, Pharmacogenomics and Genetic Architecture of Complex Human Traits. [4]

Awards and honors

Related Research Articles

<span class="mw-page-title-main">Perelman School of Medicine at the University of Pennsylvania</span> Medical school in Philadelphia, Pennsylvania, US

The Perelman School of Medicine, commonly known as Penn Med, is the medical school of the University of Pennsylvania, a private research university in Philadelphia, Pennsylvania. Founded in 1765, the Perelman School of Medicine is the oldest medical school in the United States and one of the seven Ivy League medical schools.

Multifactor dimensionality reduction (MDR) is a statistical approach, also used in machine learning automatic approaches, for detecting and characterizing combinations of attributes or independent variables that interact to influence a dependent or class variable. MDR was designed specifically to identify nonadditive interactions among discrete variables that influence a binary outcome and is considered a nonparametric and model-free alternative to traditional statistical methods such as logistic regression.

<span class="mw-page-title-main">David Botstein</span> American biologist

David Botstein is an American biologist serving as the chief scientific officer of Calico. He served as the director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University from 2003 to 2013, where he remains an Anthony B. Evnin Professor of Genomics.

David J. States is an American biophysicist who is Professor of Human Genetics at the University of Michigan. His research group is using computational methods to understand the human genome and how it relates to the human proteome. He is the Director of the Michigan NIH Bioinformatics Training Progra] and a Senior Scientist in the National Center for Integrative Biomedical Informatics.

<span class="mw-page-title-main">David Haussler</span> American bioinformatician

David Haussler is an American bioinformatician known for his work leading the team that assembled the first human genome sequence in the race to complete the Human Genome Project and subsequently for comparative genome analysis that deepens understanding the molecular function and evolution of the genome.

<span class="mw-page-title-main">Russ Altman</span>

Russ Biagio Altman is an American professor of bioengineering, genetics, medicine, and biomedical data science and past chairman of the bioengineering department at Stanford University.

<span class="mw-page-title-main">Yves A. Lussier</span>

Yves A. Lussier is a physician-scientist conducting research in Precision medicine, Translational bioinformatics and Personal Genomics. As a co-founder of Purkinje, he pioneered the commercial use of controlled medical vocabulary organized as directed semantic networks in electronic medical records, as well as Pen computing for clinicians.

<span class="mw-page-title-main">Lawrence Hunter</span>

Lawrence E. Hunter is a Professor and Director of the Center for Computational Pharmacology and of the Computational Bioscience Program at the University of Colorado School of Medicine and Professor of Computer Science at the University of Colorado Boulder. He is an internationally known scholar, focused on computational biology, knowledge-driven extraction of information from the primary biomedical literature, the semantic integration of knowledge resources in molecular biology, and the use of knowledge in the analysis of high-throughput data, as well as for his foundational work in computational biology, which led to the genesis of the major professional organization in the field and two international conferences.

<span class="mw-page-title-main">Olga Troyanskaya</span> American academic

Olga G. Troyanskaya is a Professor in the Department of Computer Science and the Lewis-Sigler Institute for Integrative Genomics at Princeton University and the Deputy Director for Genomics at the Flatiron Institute's Center for Computational Biology in NYC. She studies protein function and interactions in biological pathways by analyzing genomic data using computational tools.

<span class="mw-page-title-main">Jason H. Moore</span>

Jason H. Moore is a translational bioinformatics scientist, biomedical informatician, and human geneticist, the Edward Rose Professor of Informatics and Director of the Institute for Biomedical Informatics at the Perelman School of Medicine at the University of Pennsylvania, where he is also Senior Associate Dean for Informatics and Director of the Division of Informatics in the Department of Biostatistics, Epidemiology, and Informatics.

Translational bioinformatics (TBI) is a field that emerged in the 2010s to study health informatics, focused on the convergence of molecular bioinformatics, biostatistics, statistical genetics and clinical informatics. Its focus is on applying informatics methodology to the increasing amount of biomedical and genomic data to formulate knowledge and medical tools, which can be utilized by scientists, clinicians, and patients. Furthermore, it involves applying biomedical research to improve human health through the use of computer-based information system. TBI employs data mining and analyzing biomedical informatics in order to generate clinical knowledge for application. Clinical knowledge includes finding similarities in patient populations, interpreting biological information to suggest therapy treatments and predict health outcomes.

<span class="mw-page-title-main">Núria López Bigas</span> Researcher on computational cancer genomics

Núria López Bigas is a Spanish biologist and research professor with expertise in medical genetics, computational biology, and bioinformatics. She is an ICREA professor at Pompeu Fabra University and she also leads the Biomedical Genomics Research Group at the Institute for Research in Biomedicine in Barcelona, Spain. Her research is focused on developing computational approaches to investigate cancer genomes.

Charis Eng is a Singapore-born physician-scientist and geneticist at the Cleveland Clinic, notable for identifying the PTEN gene. She is the Chairwoman and founding Director of the Genomic Medicine Institute of the Cleveland Clinic, founding Director and attending clinical cancer geneticist of the institute’s clinical component, the Center for Personalized Genetic Healthcare, and Professor and Vice Chairwoman of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine.

Vineet Bafna is an Indian bioinformatician and professor of computer science and director of bioinformatics program at University of California, San Diego. He was elected a Fellow of the International Society for Computational Biology (ISCB) in 2019 for outstanding contributions to the fields of computational biology and bioinformatics. He has also been a member of the Research in Computational Molecular Biology (RECOMB) conference steering committee.

Keith A. Crandall is an American computational biologist, bioinformaticist, and population geneticist at George Washington University, where he is the founding director of the Computational Biology Institute, and professor in the Department of Biostatistics and Bioinformatics.

<span class="mw-page-title-main">Bissan Al-Lazikani</span> Data scientist

Professor Bissan Al-Lazikani PhD FRSB MBCS is a data scientist and drug discoverer. She applies computational techniques to help solve critical bottlenecks in cancer drug discovery and development. Since 2021 she has been professor of genomic medicine at The University of Texas MD Anderson Cancer Center.

Marisa Bartolomei is an American cell biologist, the Perelman Professor of Cell and Developmental Biology and Co-Director of the Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania. Her research considers epigenetic processes including genomic imprinting. She was elected to the National Academy of Sciences in 2021.

Biomedical data science is a multidisciplinary field which leverages large volumes of data to promote biomedical innovation and discovery. Biomedical data science draws from various fields including Biostatistics, Biomedical informatics, and machine learning, with the goal of understanding biological and medical data. It can be viewed as the study and application of data science to solve biomedical problems. Modern biomedical datasets often have specific features which make their analyses difficult, including:

<span class="mw-page-title-main">Sudhir Kumar (researcher)</span> Indian-born American scientist

Sudhir Kumar is an Indian-born American scientist whose research integrates mathematical and computational techniques into evolutionary biology and genomic medicine. His contributions include the development of widely‐used phylogenetic methods and tools, such as the MEGA software package and TimeTree resource, reconstructing the timescale of species evolution, advancing the evolutionary understanding of diseases, and insights into ecological influences on genome composition.

Daniel Richard Masys is an American biotechnologist and academic. He is an Affiliate Professor of Biomedical and Health Informatics at the University of Washington.

References

  1. "Marylyn D. Ritchie, PHD | Perelman School of Medicine at the University of Pennsylvania".
  2. "Marylyn Ritchie Honored as an Invited Kavli Fellow for the Third Year in a Row". 12 September 2013. Retrieved November 15, 2018.
  3. "Geneticist Marylyn D. Ritchie Appointed to Institute for Biomedical Informatics". April 3, 2018. Retrieved November 15, 2018.
  4. "Marylyn D. Ritchie" . Retrieved November 15, 2018.